-
Tandem – Basal IQ Now in Canada!
Great news for all you Tandem TSlim X2 pumpers! Tandem has released Basal IQ technology here in Canada! You should be receiving your email to complete the online training! I updated mine tonight and it’s looking awesome so far! #TeamTandem
-
New nasal spray launched in Canada to combat hypoglycemic shock in diabetics
A new Canadian-made medication could help people with diabetes who have gone into hypoglycemic shock. Baqsimi is a nasal spray contains three milligrams of glucagon. It differs from previously-available glucagon treatments for hypoglycemic shock, or extremely low blood sugar, because it does not need to be mixed. Lilly Canada, the…
-
Severe hypoglycemia contributes to diminished cognitive ability for older adults with type 1 diabetes
Cognitive abilities such as executive function, language and episodic memory are all negatively affected by severe hypoglycemia in adults with type 1 diabetes aged at least 60 years, according to findings published in Diabetes Care. “With recent advances in treatment, individuals with type 1 diabetes are living longer and are,…
-
Continuous glucose monitor alarm settings affect outcomes, severe hypoglycemia can lead to acute coronary syndrome
One of the week’s top stories in endocrinology was about a study that found adults with type 1 diabetes who used a higher glucose threshold for hypoglycemia alarms during continuous glucose monitor therapy spent approximately 50% less time in hypoglycemia. Findings that showed older adults with diabetes who experienced severe…
-
Higher C-peptide levels may identify lower risk for hypoglycemia …
A C-peptide level of more than 20 pmol/L may indicate a lower risk for hypoglycemia among adults with type 1 diabetes, suggesting that these individuals may safely pursue tighter glycemic targets, according to findings published in Diabetic Medicine. “Findings from [the Diabetes Control and Complications Trial] highlight that the benefit…
-
“Smart” Insulin Could Prevent Hypoglycemia During Diabetes Treatment
Bioengineers at the University of California, Los Angeles have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes. The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care for millions of people. Insulin…
-
Wearable Device for Heart Rate Variability Can Detect Early Hypoglycemia
A wearable device that measures real-time heart rate variability can detect early signs of hypoglycemia in patients with type 1 diabetes, according to study results published in Diabetes Care. To assess the ability of a wearable device to detect heart rate variability and alert users to early signs of hypoglycemia…
-
CGM shows hypoglycemia common in older adults with type 1 diabetes
NEW ORLEANS — Older adults with type 1 diabetes spent more than an hour per day on average with blood glucose levels in the hypoglycemic range and more than 20 minutes per day with levels less than 54 mg/dL, according to data presented at The Endocrine Society Annual Meeting. Anders…
-
Basal Insulin Reduction 90 Minutes Before Exercise Beneficial for Glucose Control, Hypoglycemia Risk in T1D
A 50% to 80% basal rate reduction performed 90 minutes before beginning exercise will improve open-loop glucose control and decrease the risk for hypoglycemia during exercise in individuals with type 1 diabetes, according to results of a study published in Diabetes Care. Common strategies for reducing hypoglycemia risk in active…
-
The BETTER Project || Le Projet BETTER (english and french inside)
The BETTER registry The BETTER registry is for people living with type 1 diabetes in Quebec. Its purpose is to measure the frequency and severity of episodes of hypoglycemia. The data collected in this registry is confidential and will provide a general portrait of the population with type 1 diabetes…
